miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10

Yunhong Zhang1, Xiuming Miao2, Zhen Zhang3

  • 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 18877 Jingshi Road, Jinan 250062, Shandong, China; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 18877 Jingshi Road, Jinan 250062, Shandong, China.

Insights

Increased miR-374b-5p downregulates interleukin-10 (IL-10) expression, promoting deep venous thrombosis (DVT) formation. This microRNA presents a potential diagnostic marker and therapeutic target for DVT.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Epigenetics

Background:

  • Deep venous thrombosis (DVT) is a significant cardiovascular complication.
  • Decreased interleukin-10 (IL-10) levels are implicated in DVT pathogenesis.
  • The precise molecular mechanisms behind IL-10 downregulation in DVT remain unclear.

Purpose of the Study:

  • To investigate the role of post-transcriptional epigenetic modifications in IL-10 regulation in DVT.
  • To identify specific microRNAs (miRNAs) involved in controlling IL-10 expression in DVT.
  • To explore the therapeutic potential of targeting these molecular interactions in DVT.

Main Methods:

  • miRNA expression profiling in DVT patients using microarray analysis.
  • In silico prediction and experimental validation of miRNA targets for IL-10.
  • Quantitative real-time PCR (qRT-PCR) and enzyme-linked immunoassay for IL-10 and miR-374b-5p.
  • Dual luciferase reporter assays to confirm direct miRNA-mRNA interaction.
  • Murine DVT models to assess the in vivo effects of miR-374b-5p modulation.

Main Results:

  • IL-10 expression was significantly decreased, while miR-374b-5p levels were elevated in DVT patients.
  • A strong negative correlation was observed between miR-374b-5p and IL-10 expression.
  • Overexpression of miR-374b-5p reduced IL-10, whereas its inhibition increased IL-10 levels.
  • In vivo studies confirmed that elevated miR-374b-5p aggravated DVT, while its inhibition ameliorated the condition.
  • Direct binding of miR-374b-5p to the IL10 gene was experimentally verified.

Conclusions:

  • Elevated miR-374b-5p promotes DVT by suppressing IL-10 expression.
  • miR-374b-5p represents a promising diagnostic biomarker for DVT.
  • Targeting miR-374b-5p offers a potential therapeutic strategy for managing DVT.
Abstract